Waiting
Login-Verarbeitung ...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Analyse af kombinatorisk miRNA behandlinger til…
JoVE Journal
Cancer Research
Author Produced

Ein Abonnement für JoVE ist erforderlich, um diesen Inhalt ansehen zu können. Melden Sie sich an oder starten Sie Ihre kostenlose Testversion.

JoVE Journal Cancer Research
Analyse af kombinatorisk miRNA behandlinger til at regulere cellecyklus og angiogenese
Microfluidic Shear Apparatus Setup for Single-Cell Fluid Shear Assay (Video) | JoVE
Journal (Cancer Research)
Microfluidic Shear Apparatus Setup for Single-Cell Fluid Shear Assay (Video) | JoVE
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Journal (Cancer Research)
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
 
Click here for the English version

Analyse af kombinatorisk miRNA behandlinger til at regulere cellecyklus og angiogenese

Article DOI: 10.3791/59460-v • 11:44 min • March 30th, 2019
March 30th, 2019 •
1, 1, 2, 3, 1, 1, 2, 1
1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, 2Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 3Department of Obstetrics and Gynecology, School of Medicine, Texas Tech University Health Sciences Center

Kapitel

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

miRNA therapeutics har betydeligt potentiale i at regulere kræft progression. Vist her er analytiske tilgange bruges til identifikation af aktiviteten af en kombinatoriske miRNA behandling standse cellecyklus og angiogenese.

Tags

Kræftforskning sag 145 Transfektion miRNA lungekræft celle cyklus apoptose angiogenese RNA sekventering
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter